img

Glimepiride

Glimepiride is an orally available medium-to-long-acting sulfonylurea antidiabetic drug. It is sometimes classified as either the first third-generation sulfonylurea, or as second-generation. More

Sharing is caring, show love and share the thread with your friends.

Description

Glimepiride is an orally available medium-to-long-acting sulfonylurea antidiabetic drug. It is sometimes classified as either the first third-generation sulfonylurea, or as second-generation.

Generic Name

Glimepiride

Chemical names

Glimepiride; Amaryl; Amarel; Glimepirida

Brand names

Abepride, Adglim, Adride, Amaryl, Asoride, Astapride, Azulix, Beglim, Bepride, Betaglim, Blisto, Capril, Cgryl, Chempride, Conpride, Cupride, Daoride, Daoryl, Diaglim, Diagraph, Diapride, Diaset, Diaswich, Diazero, Dibiglim, Dipride, Elim, Emperide, Euglim, Euroglip, Flexiglim, G-Tab, G-Tab Forte, G-Tab M, Gadz, Geminor, Gepride, Gimip, Gitae, Givov, Glador, Glamor, Gleam, Gli, Glicmiz, Glicon-M, Glimcare, Glimchek, Glimcip, Glimcom

IUPAC name

3-ethyl-4-methyl-2-oxo-N-(2-{4-[({[(1r,4r)-4-methylcyclohexyl]-C-hydroxycarbonimidoyl}amino)sulfonyl]phenyl}ethyl)-2,5-dihydro-1H-pyrrole-1-carboximidic acid

Pharmacokinetics

Oral absorption 100%. Hepatic metabolism.

Actions

Glimepiride, like glyburide and glipizide, is a "second-generation" sulfonylurea agents. This lowers the blood glucose by increasing the secretion of insulin from pancreas and increasing the sensitivity of peripheral tissues to insulin with diet.

Dosage/Dosage form

The recommended dose is 1-2 mg once daily with food PO.

Therapeutic uses

For concomitant use with insulin for the treatment of noninsulin-dependent (type 2) diabetes mellitus.

Adverse effects/Side effects

Vomiting, GI pain, diarrhoea; pruritus, erythema, urticaria, morbilliform, maculopapular eruptions; leukopenia, agranulocytosis, thrombocytopenia, haemolytic anaemia, aplastic anaemia and pancytopenia; hyponatraemia; changes in accommodation, blurred vision, jaundice.

Interaction

  • Corticosteroids, thiazides and other diuretics, phenothiazines, oestrogens, thyroid products, oral contraceptives, nicotinic acid, phenytoin, sympathomimetics, rifampicin, CYP2C9 inducers and isoniazid may reduce hypoglycaemic effect of glimepiride.
  • NSAIDs, sulphonamides, salicylates, coumarin, chloramphenicol, CYP2C9 inhibitors, probenecid, fibric acid derivatives, TCAs, pegvisomant, MAOIs and β-adrenergic blockers may potentiate the hypoglycaemic action of glimepiride.
  • May increase the serum levels of ciclosporin. Serum levels may be increased by fluconazole.
  • May increase the serum levels of ciclosporin.
  • Serum levels may be increased by fluconazole.

Contraindications

Diabetic ketoacidosis with or without coma

Storage

Store at 15-30°C

Information

Molecular weight

490.62

Molecular formula

C24H34N4O5S

CAS number

93479-97-1

Precautions

  • Increased risk of CV mortality.
  • Elderly; hepatic and renal impairment.
  • Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in patients with CHF or hepatic cirrhosis.
  • Monitor blood-glucose concentration.
  • Pregnancy, lactation.